Week Ending August 30, 2021

The White Ribbon Project comes to UC Davis to acknowledge efforts in tackling lung cancer
“Retired linebacker Chris Draft, who played on the 49ers and the Falcons as well as other NFL teams, was at UC Davis Comprehensive Cancer Center on Tuesday, Aug. 24, to acknowledge efforts by the cancer center to tackle lung cancer.”

Immunotherapy For Lung Cancer Adopted Quickly, Has Real World Efficacy
“The IMpower133 trial (NCT02763579) helped to establish immunotherapy’s usefulness in extensive-stage small cell lung cancer (ES-SCLC). However, questions remain around atezolizumab’s (Tecentriq) real-world efficacy and uptake.”

Working Behind the Scenes for Patients With Lung Cancer
“Jody Ruth Steinhardt, M.P.H., CHES, is the coordinator of the lung cancer screening program at Maimonides Medical Center, where she started her career 30 years ago as the oncology program coordinator.”

AI Blood Test Proves Useful in Lung Cancer Detection
— Such an approach would be useful considering the barriers to LDCT among high-risk people
“A blood test powered by the use of artificial intelligence could be an effective pre-screening tool for the noninvasive detection of lung cancer, according to a prospective study.”

Biomarker Testing in Lung Cancer Continues to Improve Outcomes, Move the Field Forward
“Years ago, many patients with lung cancer were treated the same, as there was limited knowledge about the disease and limited therapies to treat it. Then, biomarker testing brought precision medicine into the world of lung cancer, and now patients are treated with drugs specifically designed to treat cancer with certain characteristics.”

What paraneoplastic syndromes are connected to small cell lung cancer?
“Paraneoplastic syndrome is a group of rare autoimmune diseases that can occur due to lung cancer, especially small cell lung cancer (SCLC). The group of diseases occur due to the immune system mistakenly attacking nerve cells.”

Early Target Identification Will Help Maximize Osimertinib Treatment
“Expanding the use of osmertinib (Tagrisso) so that it is efficacious as a frontline treatment will help pave the way for a new era of success in treating lung cancer, said Jonathan W. Riess, MD, MS”

RET Fusion–Positive Non–Small Cell Lung Cancer
“This is Part 1 of Updates in Lung Cancer, a four-part video roundtable series. Scroll down to watch the other videos from this Roundtable.”